January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
FerroptoCure Inc.
FerroptoCure is a clinical stage company developing novel new ferroptosis inducing anti-cancer therapy. FerroptoCure has completed a Phase1a trial of the lead project in Japan and seeking partners to out-license and investors.